Predictors of Prosthetic Valve Regurgitation After Transcatheter Aortic Valve Implantation With ACURATE neo in the SCOPE I Trial.
暂无分享,去创建一个
B. Prendergast | H. Thiele | M. Joner | S. Windecker | T. Walther | S. Redwood | C. Thilo | L. Conradi | D. Heg | J. Lanz | S. Stortecky | T. Pilgrim | Won-Keun Kim | J. Blumenstein | H. Möllmann | A. Linke | C. Burgdorf | L. Conzelmann | O. Husser | M. Hilker | T. Rheude | S. Barth
[1] B. Prendergast,et al. One-Year Outcomes of a Randomized Trial Comparing a Self-Expanding With a Balloon-Expandable Transcatheter Aortic Valve. , 2021, Circulation.
[2] B. Prendergast,et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial , 2019, The Lancet.
[3] T. Walther,et al. The ACURATE neo Transcatheter Heart Valve: A Comprehensive Analysis of Predictors of Procedural Outcome. , 2018, JACC. Cardiovascular interventions.
[4] J. Leipsic,et al. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve , 2017, JAMA cardiology.